Search research articles
Contact Us
Filters
Showing results (51-60 of 72) with videos related to
Page
of 8
Sort By:
Metabolism: Clinical and Experimental
|
May 20, 2017
siRNA-mediated inhibition of SREBP cleavage-activating protein reduces dyslipidemia in spontaneously dysmetabolic rhesus monkeys
Beth Ann Murphy, Marija Tadin-Strapps, Kristian Jensen, et al.
Thrombosis Journal
|
June 4, 2014
Thrombin based gelatin matrix and fibrin sealant mediated clot formation in the presence of clopidogrel
Joseph F Dwyer, Jill A McCoy, Ziping Yang, et al.
The Oncologist
|
March 24, 2026
Cancer: A looming public health crisis in Africa-a call to accelerate equitable access to medicines
Rose I Anorlu, Lemchukwu C Amaeshi, Kehinde S Okunade, et al.
International Journal of Audiology
|
March 21, 2018
Targeting the psychosocial and functional fitness challenges of older adults with hearing loss: a participatory approach to adaptation of the walk and talk for your life program
Marc Jutras, Justin Lambert, Jiyoung Hwang, et al.
Irish Journal of Medical Science
|
December 25, 2019
Implications of faecal ESBL carriers undergoing TRUS-guided prostate biopsy (TRUSPB): role of screening prior to TRUSPB
Nikita R Bhatt, Catherine Ann Murphy, Niall Wall, et al.
Stem Cells (Dayton, Ohio)
|
March 16, 2016
Tribute to Donald Metcalf
Ann Murphy, Martin J Murphy, C Glenn Begley, et al.
Pharmacology Research & Perspectives
|
March 30, 2016
Potential mechanism of enhanced postprandial glucagon-like peptide-1 release following treatment with a diacylglycerol acyltransferase 1 inhibitor
Jinqi Liu, David G McLaren, Dunlu Chen, et al.
Trials
|
January 29, 2017
Targeting functional fitness, hearing and health-related quality of life in older adults with hearing loss: Walk, Talk 'n' Listen, study protocol for a pilot randomized controlled trial
Justin Lambert, Rouzbeh Ghadry-Tavi, Kate Knuff, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 10, 2010
Pyrido[2,3-b]pyrazines, discovery of TRPV1 antagonists with reduced potential for the formation of reactive metabolites
Kevin J Hodgetts, Charles A Blum, Timothy Caldwell, et al.
Pharmaceutical Development and Technology
|
April 27, 2013
Paclitaxel nanosuspensions for targeted chemotherapy - nanosuspension preparation, characterization, and use
Sarah E Lee, Shawn F Bairstow, Jane O Werling, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 72) with videos related to
Sort By:
Page
of 8
Metabolism: Clinical and Experimental
|
May 20, 2017
siRNA-mediated inhibition of SREBP cleavage-activating protein reduces dyslipidemia in spontaneously dysmetabolic rhesus monkeys
Beth Ann Murphy, Marija Tadin-Strapps, Kristian Jensen, et al.
Thrombosis Journal
|
June 4, 2014
Thrombin based gelatin matrix and fibrin sealant mediated clot formation in the presence of clopidogrel
Joseph F Dwyer, Jill A McCoy, Ziping Yang, et al.
The Oncologist
|
March 24, 2026
Cancer: A looming public health crisis in Africa-a call to accelerate equitable access to medicines
Rose I Anorlu, Lemchukwu C Amaeshi, Kehinde S Okunade, et al.
International Journal of Audiology
|
March 21, 2018
Targeting the psychosocial and functional fitness challenges of older adults with hearing loss: a participatory approach to adaptation of the walk and talk for your life program
Marc Jutras, Justin Lambert, Jiyoung Hwang, et al.
Irish Journal of Medical Science
|
December 25, 2019
Implications of faecal ESBL carriers undergoing TRUS-guided prostate biopsy (TRUSPB): role of screening prior to TRUSPB
Nikita R Bhatt, Catherine Ann Murphy, Niall Wall, et al.
Stem Cells (Dayton, Ohio)
|
March 16, 2016
Tribute to Donald Metcalf
Ann Murphy, Martin J Murphy, C Glenn Begley, et al.
Pharmacology Research & Perspectives
|
March 30, 2016
Potential mechanism of enhanced postprandial glucagon-like peptide-1 release following treatment with a diacylglycerol acyltransferase 1 inhibitor
Jinqi Liu, David G McLaren, Dunlu Chen, et al.
Trials
|
January 29, 2017
Targeting functional fitness, hearing and health-related quality of life in older adults with hearing loss: Walk, Talk 'n' Listen, study protocol for a pilot randomized controlled trial
Justin Lambert, Rouzbeh Ghadry-Tavi, Kate Knuff, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 10, 2010
Pyrido[2,3-b]pyrazines, discovery of TRPV1 antagonists with reduced potential for the formation of reactive metabolites
Kevin J Hodgetts, Charles A Blum, Timothy Caldwell, et al.
Pharmaceutical Development and Technology
|
April 27, 2013
Paclitaxel nanosuspensions for targeted chemotherapy - nanosuspension preparation, characterization, and use
Sarah E Lee, Shawn F Bairstow, Jane O Werling, et al.
Page
of 8